COHLHEPP RYAN (President and COO) sold 6.0% of their position (12.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $287.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/17/2026ACC: 0001628280-26-025817
DirectorOfficer· President and COO
Since Mar 2026
-12.50K
Net shares
Net seller
$287.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
8K acquired · 20.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8K
Price / share
$3.79
Trade value
$30.32K
% of position
4.0%
4/15/2026
200.64K→208.64K
Common Stock
Direct
Shares
−8K
Price / share
$23.01
Trade value
$184.06K
% of position
3.8%
4/15/2026
208.64K→200.64K
Common Stock
Direct
Shares
−4.50K
Price / share
$23.01
Trade value
$103.53K
% of position
2.2%
4/15/2026
200.64K→196.14K
Total
Net shares
−4.50K
Net value
-$257.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | M · Option Exercise | +8K | $3.79 | $30.32K | 4.0% | 200.64K | 208.64K |
| Common Stock Direct | 4/15/2026 | S · Sale | −8K | $23.01 | $184.06K | 3.8% | 208.64K | 200.64K |
| Common Stock Direct | 4/15/2026 | S · Sale | −4.50K | $23.01 | $103.53K | 2.2% | 200.64K | 196.14K |
| Total | −4.50K | -$257.27K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
3.7898
Held after
109.33K
Exercisable
—
4/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8K shares | 4/15/2026 | M · Option Exercise | −8K | 3.7898 | — | 109.33K |